Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Takanori Takenawa"'
Autor:
Takanori Takenawa, Koji Harada, Tarannum Ferdous, Keisuke Kawasaki, Yasuhiro Kuramitsu, Katsuaki Mishima
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 35:282-287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25706808de1dc289525463b315beb173
https://doi.org/10.1016/j.ajoms.2022.10.004
https://doi.org/10.1016/j.ajoms.2022.10.004
Autor:
Yasutaka Itashiki, Takanori Takenawa, Tarannum Ferdous, Koji Harada, Katsuaki Mishima, Yoshiya Ueyama
Publikováno v:
Oncology Letters
Vascular endothelial growth factor (VEGF) serves an important role in new blood vessel formation or angiogenesis, which is a critical event in tumor growth and metastasis. Bevacizumab is a humanized monoclonal antibody against VEGF-A, whereas S-1 is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa3bf7ab418d50b19038f59a9096baa
https://pubmed.ncbi.nlm.nih.gov/34429770
https://pubmed.ncbi.nlm.nih.gov/34429770
Autor:
KOJI HARADA1 harako@yamaguchi-u.ac.jp, TAKANORI TAKENAWA1, TARANNUM FERDOUS1, YASUHIRO KURAMITSU2, YOSHIYA UEYAMA1
Publikováno v:
Oncology Letters. Jun2017, Vol. 13 Issue 6, p4857-4862. 6p.
Publikováno v:
Oncology Letters. 14:3349-3356
Gimeracil or 5-chloro-2,4-dihydroxypyridine (CDHP) enhances the antitumor effects of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase (DPD), which is involved in the degradation of 5-FU. CDHP, as part of a combination therapy, was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e8102a5e5fe529f76541ed889027e69
https://doi.org/10.3892/ol.2017.6602
https://doi.org/10.3892/ol.2017.6602
Publikováno v:
Mol Clin Oncol
Elental(®) is an L-glutamine-rich elemental diet (ED) that has been widely used in Japan as a nutritional supplement for malnourished patients. In addition, Elental(®) has been successfully used in the management of chemotherapy-induced mucositis i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594f2d7c56de4f32106222645870267d
https://pubmed.ncbi.nlm.nih.gov/32699632
https://pubmed.ncbi.nlm.nih.gov/32699632
Autor:
Jutaro Miyamoto, Takanori Takenawa, Nagahiro Tsuboi, Yoshiya Ueyama, Kenichiro Uchida, Takahiro Fujii
Publikováno v:
Japanese Journal of Oral and Maxillofacial Surgery. 63:645-652
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61d62ae3a308ff533e32955e66870c59
https://doi.org/10.5794/jjoms.63.645
https://doi.org/10.5794/jjoms.63.645
Publikováno v:
Molecular Medicine Reports
The use of stem cells represents a promising approach for the treatment of bone defects. However, successful treatments rely upon the availability of cells that are easily obtained and that appropriately differentiate into osteoblasts. The tongue pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f00e950b509b8c1d80c65fe57b31fd1
https://doi.org/10.3892/mmr.2015.3350
https://doi.org/10.3892/mmr.2015.3350
We focused on the expression of Calreticulin (CALR) in oral squamous cell carcinoma (OSCC) on the basis of proteomic differential display analysis data. We used QR-32 cells in this study which is a regressive murine fibrosarcoma cell clone; and QRsP-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955b1993cd9b52c70fbf2171e178823e
https://europepmc.org/articles/PMC5452987/
https://europepmc.org/articles/PMC5452987/
Expression of calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma
Publikováno v:
Annals of Oncology. 27:vi345
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdde6fe105a73600d4b4124af3814f2a
https://doi.org/10.1093/annonc/mdw376.53
https://doi.org/10.1093/annonc/mdw376.53
Autor:
Takanori, Takenawa, Yasuhiro, Kuramitsu, Yufeng, Wang, Futoshi, Okada, Kazuhiro, Tokuda, Takao, Kitagawa, Yoshiya, Ueyama, Kazuyuki, Nakamura
Publikováno v:
Anticancer research. 33(1)
Important strategies against cancer are based on the understanding of the mechanisms of tumor progression. To elucidate alterations regarding tumor progression, we have performed proteomic differential display analysis for the expression of intracell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d8e980ca42a5216f0749ee3448b508a
https://pubmed.ncbi.nlm.nih.gov/23267140
https://pubmed.ncbi.nlm.nih.gov/23267140